CCM
IDXX icon

Carderock Capital Management’s Idexx Laboratories IDXX Stock Holding History

Carderock Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.75M Buy
16,627
+161
+1% +$90.3K 1.92% 22
2026
Q1 		$9.25M Sell
16,466
-309
-2% -$198K 2.29% 18
2025
Q4 		$11.3M Sell
16,775
-209
-1% -$142K 2.75% 11
2025
Q3 		$10.9M Buy
16,984
+538
+3% +$327K 2.64% 9
2025
Q2 		$8.82M Buy
16,446
+2,017
+14% +$965K 2.26% 17
2025
Q1 		$6.06M Buy
14,429
+660
+5% +$287K 1.61% 35
2024
Q4 		$5.69M Sell
13,769
-718
-5% -$315K 1.43% 39
2024
Q3 		$7.32M Sell
14,487
-277
-2% -$135K 1.73% 33
2024
Q2 		$7.19M Buy
14,764
+473
+3% +$237K 1.88% 29
2024
Q1 		$7.72M Sell
14,291
-2,125
-13% -$1.16M 2.16% 21
2023
Q4 		$9.11M Buy
16,416
+4,315
+36% +$2.03M 2.52% 10
2023
Q3 		$5.29M Buy
12,101
+1,448
+14% +$722K 1.78% 33
2023
Q2 		$5.35M Buy
10,653
+2,403
+29% +$1.15M 1.66% 33
2023
Q1 		$4.13M Buy
8,250
+2,079
+34% +$995K 1.44% 39
2022
Q4 		$2.52M Buy
6,171
+801
+15% +$311K 1.04% 44
2022
Q3 		$1.75M Sell
5,370
-915
-15% -$336K 0.89% 44
2022
Q2 		$2.2M Sell
6,285
-1,506
-19% -$614K 0.92% 50
2022
Q1 		$4.26M Sell
7,791
-7,950
-51% -$4.18M 1.38% 38
2021
Q4 		$10.4M Sell
15,741
-33
-0.2% -$20.7K 2.49% 10
2021
Q3 		$9.81M Sell
15,774
-65
-0.4% -$43.7K 2.76% 10
2021
Q2 		$10M Sell
15,839
-497
-3% -$274K 2.74% 7
2021
Q1 		$7.99M Sell
16,336
-3,084
-16% -$1.55M 2.39% 8
2020
Q4 		$9.71M Buy
19,420
+20
+0.1% +$8.95K 2.93% 7
2020
Q3 		$7.63M Sell
19,400
-1,627
-8% -$602K 2.58% 10
2020
Q2 		$6.94M Buy
21,027
+173
+0.8% +$50.1K 2.56% 9
2020
Q1 		$5.05M Sell
20,854
-158
-0.8% -$41.2K 2.32% 12
2019
Q4 		$5.49M Buy
21,012
+68
+0.3% +$17.9K 1.84% 21
2019
Q3 		$5.7M Sell
20,944
-1,590
-7% -$442K 2.1% 16
2019
Q2 		$6.2M Sell
22,534
-723
-3% -$178K 2.34% 10
2019
Q1 		$5.2M Buy
23,257
+1,144
+5% +$236K 2.12% 18
2018
Q4 		$4.11M Sell
22,113
-7,486
-25% -$1.53M 2.12% 19
2018
Q3 		$7.39M Sell
29,599
-76
-0.3% -$18.4K 2.92% 5
2018
Q2 		$6.47M Sell
29,675
-1,019
-3% -$210K 2.79% 5
2018
Q1 		$5.88M Sell
30,694
-4,796
-14% -$885K 2.59% 7
2017
Q4 		$5.55M Sell
35,490
-720
-2% -$113K 2.45% 7
2017
Q3 		$5.63M Sell
36,210
-1,696
-4% -$268K 2.54% 9
2017
Q2 		$6.12M Sell
37,906
-1,181
-3% -$192K 2.76% 5
2017
Q1 		$6.04M Sell
39,087
-16,943
-30% -$2.34M 2.8% 5
2016
Q4 		$6.57M Sell
56,030
-1,024
-2% -$117K 3.28% 1
2016
Q3 		$6.43M Sell
57,054
-1,142
-2% -$120K 3.22% 1
2016
Q2 		$5.4M Sell
58,196
-1,916
-3% -$165K 2.86% 6
2016
Q1 		$4.71M Sell
60,112
-40
-0.1% -$2.88K 2.42% 13
2015
Q4 		$4.39M Buy
60,152
+293
+0.5% +$20.9K 2.28% 13
2015
Q3 		$4.45M Buy
59,859
+282
+0.5% +$20.2K 2.48% 12
2015
Q2 		$3.82M Sell
59,577
-4,923
-8% -$341K 1.92% 21
2015
Q1 		$4.98M Buy
64,500
+186
+0.3% +$14.5K 2.41% 10
2014
Q4 		$4.77M Buy
64,314
+1,508
+2% +$106K 2.35% 12
2014
Q3 		$3.7M Sell
62,806
-1,548
-2% -$97.9K 1.9% 23
2014
Q2 		$4.3M Sell
64,354
-3,854
-6% -$245K 2.24% 15
2014
Q1 		$4.14M Sell
68,208
-1,688
-2% -$101K 2.1% 14
2013
Q4 		$3.72M Sell
69,896
-5,856
-8% -$308K 1.95% 19
2013
Q3 		$3.77M Sell
75,752
-2,672
-3% -$128K 2.19% 14
2013
Q2 		$3.52M Buy
+78,424
New +$3.43M 2.08% 15

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Carderock Capital Management's IDXX Position: Q2 2026 in Review

Carderock Capital Management increased its Idexx Laboratories (IDXX) stake by 0.98% in Q2 2026, buying an estimated $90.3K and bringing the position to 16,627 shares worth $8.75M. The position accounts for 1.92% of the portfolio, ranked #22.

Carderock Capital Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.3M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Carderock Capital Management held 16,627 shares of Idexx Laboratories worth $8.75M as of Q2 2026.
  • Carderock Capital Management bought 161 Idexx Laboratories shares in Q2 2026, an estimated $90.3K.
  • Idexx Laboratories made up 1.92% of Carderock Capital Management's portfolio in Q2 2026, its #22 holding.
  • Carderock Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Carderock Capital Management's Idexx Laboratories position peaked at $11.3M in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.